Hydroxyurea

Hydroxyurea has been studied in 9 papers since 2018: 2 observational studies in people, 1 in animals, 4 in cells, 2 reviews; 5 in the past year. The newest paper, Oct 25, 2026: “Management of Elderly and Frail Patients with Philadelphia-Negative Myeloproliferative Neoplasms—A Narrative Review”.

Intervention

9 papers study it24 more mention it6 findingsUpdated

PubChemChEBIMeSH

1 new paper in 30 daysSee all 33 papers on hydroxyurea

At a glance

The findings reach people, from one lab or study; independent labs found the same change in cells. 6 independent labs in 4 countries; 144 trials, 55 with no results posted.

“CH was not associated with exposure to hydroxyurea therapy (OR, 0.76; P = .44)”
Increased prevalence of clonal hematopoiesis in children with sickle cell diseaseBlood2025doi:10.1182/blood.2025030898

None of its findings points the other way.

Cells: replicated by independent labs. Worms or flies and humans: a single group. Mice: nothing yet.
  • 6 independent labs in 4 countries
  • 144 trials, 55 with no results posted
  • Funders: National Heart, Lung, and Blood Institute and others
  • 1 of 6 findings with company ties
  • 5 of 144 trials sponsored by its developers
  • Humans2
  • Animals1
  • Cells4

What did studies of hydroxyurea find?

4

Studies of hydroxyurea measured 4 outcomes, among them cellular senescence, clonal hematopoiesis of indeterminate potential and MCC vacuolation.

Cellular senescence

upin human cells1upin mouse cells1

2 studies
  1. Hydroxyurea induces cellular senescence in HK-2 proximal tubular cells (greatest fold-changes).

    Cellsin HK-2 proximal tubular cells100 μM

  2. Hydroxyurea increases cellular senescence in Polb-null mouse embryonic fibroblasts, compared with wild-type treated with hydroxyurea.

    Cellsin Polb-null mouse embryonic fibroblasts, compared with wild-type treated with hydroxyurea

More on Cellular senescence

Clonal hematopoiesis of indeterminate potential

no changein humans1OR 0.76

1 study
  1. Hydroxyurea was not clearly linked with clonal hematopoiesis of indeterminate potential in humans (children with sickle cell disease) (OR 0.76; P = .44).

    Humanschildren with sickle cell disease

More on Clonal hematopoiesis of indeterminate potential

MCC vacuolation

upin mouse cells1

1 study
  1. Hydroxyurea induces MCC vacuolation in vitro organotypic culture.

    Cellsin vitro organotypic culture

Chronological lifespan

upin yeast cells1

1 study
  1. Hydroxyurea extends chronological lifespan in yeast cells (exposure during growth, but not during stationary phase).

    Cellsexposure during growth, but not during stationary phaselow doses

What is hydroxyurea linked with?

1

Studies link hydroxyurea with telomere length.

Telomere length

downin humans1

1 study
  1. Hydroxyurea is associated with telomere length in humans (sickle cell disease; multivariate analysis; possible confounding by disease severity) (β = -0.194, 95% CI -0.250 to -0.138; p < 0.001).

    Humanssickle cell disease; multivariate analysis; possible confounding by disease severityleukocyten = 2,620

More on Telomere length

Trial sponsors

Latest

Dec 2025: 2Jan 2026: 1Feb 2026: 0Mar 2026: 1Apr 2026: 1May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 3Nov 2026: 010 papers in 12 months

See all 33 papers on hydroxyurea